Patent Assignment
Reel/Frame 059600/0200
Assignment of Assignor's Interest
Recorded: 2022-04-14
Pages: 8
Assignors
TAMBURINI, JEROME
Executed: 2022-04-04
DECROOCQ, JUSTINE
Executed: 2022-04-06
SARRY, JEAN-EMMANUEL
Executed: 2022-03-04
BOUSCARY, DIDIER
Executed: 2022-03-03
BIRSEN, RUDY
Executed: 2022-04-02
Assignees
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
101, RUE DE TOLBIAC, PARIS, 75013, FRANCE
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
3, RUE MICHEL ANGE, PARIS, 75016, FRANCE
UNIVERSITE TOULOUSE III - PAUL SABATIER
118 ROUTE DE NARBONNE, TOULOUSE, 31400, FRANCE
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)
3, AVENUE VICTORIA, PARIS, 75004, FRANCE
UNIVERSITE DE PARIS
85 BOULEVARD SAINT-GERMAIN, PARIS, 75006, FRANCE
Covered Property
(1)
Use of Pyrvinium for the Treatment of a Ras Pathway Mutated Acute Myeloid Leukemia
Application:
17/639,477 →
Publication:
US 2022/0288040
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
Corrective Assignment to Correct the Property Number 16930208 Previously Recorded at Reel: 060390 Frame: 0122. Assignor(S) Hereby Confirms the Change of Name.
Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →